These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 481383

  • 21. [Personal experience with the use of sisomicin in pediatric pathology].
    Randazzo S, Moncada I.
    Minerva Pediatr; 1983 May 31; 35(10):531-4. PubMed ID: 6877200
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Efficacy, tolerance, and pharmacokinetics of sisomicin in urinary tract infections (author's transl)].
    Dobbelstein H, Isbary E, Lang W.
    Infection; 1978 May 31; 6(6):271-6. PubMed ID: 103844
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)].
    Lode H, Kemmerich B, Koeppe P, Langmaack H.
    Dtsch Med Wochenschr; 1975 Oct 17; 100(42):2144-50. PubMed ID: 1164890
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Clinical studies on the effect and tolerance of Refobacin].
    Grun R.
    Med Welt; 1972 Nov 18; 23(47):1769-75. PubMed ID: 4638160
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of sisomicin and gentamicin in bacteriuric patients with underlying diseases of the urinary tract.
    Klastersky J, Hensgens C, Gerard M, Daneau D.
    Antimicrob Agents Chemother; 1975 Jun 18; 7(6):742-7. PubMed ID: 1155918
    [Abstract] [Full Text] [Related]

  • 33. Sisomicin in urinary tract infection: Tolerance and efficacy study.
    Etra W, Surgalla M, Wajsman Z, Baumgartner G, Merrin C.
    Urology; 1976 Feb 18; 7(2):160-4. PubMed ID: 1246785
    [Abstract] [Full Text] [Related]

  • 34. Treatment with sisomicin of complicated urinary tract infections in patients with varying degrees of renal function impairment, pharmacokinetics and dosage adjustment.
    Mosegaard A, Welling PG, Tse FL, Madsen P.
    Infection; 1975 Feb 18; 3(3):143-7. PubMed ID: 1223005
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
    Bonadio M, Maccanti O, Pulitanò L, Galigani P, Palla R.
    G Ital Chemioter; 1985 Feb 18; 32(2):459-63. PubMed ID: 3914435
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.
    Roth S, Naber K, Scheer M, Gruenwaldt G, Lange H.
    Eur J Clin Pharmacol; 1976 Sep 30; 10(5):357-65. PubMed ID: 789084
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.